112 related articles for article (PubMed ID: 6815362)
21. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
[TBL] [Abstract][Full Text] [Related]
22. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
[TBL] [Abstract][Full Text] [Related]
23. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
Legius E; Marchuk DA; Collins FS; Glover TW
Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
[TBL] [Abstract][Full Text] [Related]
24. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.
Badache A; Muja N; De Vries GH
Oncogene; 1998 Aug; 17(6):795-800. PubMed ID: 9715282
[TBL] [Abstract][Full Text] [Related]
25. [Neurofibrosarcoma with glandular differentiation. Apropos of a case].
Després S; Doliveux P; Laurent M; Nezelof C
Arch Anat Pathol (Paris); 1973 Mar; 21(1):59-62. PubMed ID: 4634030
[No Abstract] [Full Text] [Related]
26. The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors.
Brooks DG
Neurosurg Clin N Am; 2004 Apr; 15(2):145-55. PubMed ID: 15177314
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
28. Neoplastic transformation of newborn rat oligodendrocytes in culture.
Bressler JP; Cole R; de Vellis J
Cancer Res; 1983 Feb; 43(2):709-15. PubMed ID: 6848186
[TBL] [Abstract][Full Text] [Related]
29. Giant plexiform neurofibroma in a patient with neurofibromatosis type I.
Rallis E; Ragiadakou D
Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985
[TBL] [Abstract][Full Text] [Related]
30. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
31. Case 3: Neurofibromatosis I with metastases from a thigh neurofibrosarcoma.
Ramirez JA; Montesinos JJ
AJR Am J Roentgenol; 1998 Sep; 171(3):837, 841-2. PubMed ID: 9725330
[No Abstract] [Full Text] [Related]
32. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
33. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
34. Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors.
Lothe RA; Smith-Sørensen B; Hektoen M; Stenwig AE; Mandahl N; Saeter G; Mertens F
Genes Chromosomes Cancer; 2001 Feb; 30(2):202-6. PubMed ID: 11135438
[TBL] [Abstract][Full Text] [Related]
35. Pediatric neurofibrosarcoma.
Neville H; Corpron C; Blakely ML; Andrassy R
J Pediatr Surg; 2003 Mar; 38(3):343-6; discussion 343-6. PubMed ID: 12632346
[TBL] [Abstract][Full Text] [Related]
36. Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors.
Kurtz A; Lueth M; Kluwe L; Zhang T; Foster R; Mautner VF; Hartmann M; Tan DJ; Martuza RL; Friedrich RE; Driever PH; Wong LJ
Mol Cancer Res; 2004 Aug; 2(8):433-41. PubMed ID: 15328370
[TBL] [Abstract][Full Text] [Related]
37. [Cutaneous manifestations of type 1 neurofibromatosis and their treatment].
Lantiéri L; Wolkenstein P
Ann Chir Plast Esthet; 1998 Aug; 43(4):445-54. PubMed ID: 9926476
[TBL] [Abstract][Full Text] [Related]
38. The demonstration of tissue clonality by X-linked enzyme histochemistry.
Thomas GA; Williams D; Williams ED
J Pathol; 1988 Jun; 155(2):101-8. PubMed ID: 3164772
[TBL] [Abstract][Full Text] [Related]
39. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
